期刊文献+

孟鲁司特钠治疗儿童感染后咳嗽的临床疗效观察 被引量:14

Observation of Curative Effects of Montelukast Sodium on Post Infectious Cough in Children
暂未订购
导出
摘要 目的:观察白三烯受体拮抗剂孟鲁司特钠治疗儿童感染后咳嗽的临床疗效。方法:我院2010年4月~2011年4月诊治的感染后咳嗽患儿129例,随机分为对照组、布地奈德治疗组和孟鲁司特钠治疗组共三组,分别给予阿奇霉素干混悬剂、阿奇霉素干混悬剂联合布地奈德及阿奇霉素干混悬剂联合孟鲁司特钠治疗,观察三组咳嗽症状评分变化、显效时间及有效率。结果:与对照组比较,孟鲁司特钠和布地奈德可以明显改善感染后咳嗽患儿的咳嗽症状评分、缩短显效时间、提高总有效率(P<0.05),但孟鲁司特钠治疗组和布地奈德治疗组两者间比较差异无统计学意义(P>0.05)。结论:孟鲁司特钠治疗儿童感染后咳嗽疗效明确、依从性好,值得临床推广。 Objective:To observe the curative effects of leukotriene receptor antagonists montelukast sodium on post infectionem cough in children.Methods:Randomly 129 cases of post infectionem cough were allocated into three groups,treated with azithromycin suspension,azithromycin suspension combined with budesonide atomization inhalation,and azithromycin suspension combined with montelukast sodium,respectively.The cough sign score,improvement time and total effective rate were compared between the three groups.Results:Budesonide and montelukast sodium combined with azithromycin therapy could improve the cough sign score,shorten improvement time,and increase total effective rate apparently,as compared to the control group(P0.05).But there were no differences between the two treatment groups(P0.05).Conclusions:Montelukast sodium showed a better curative effect on post infectionem cough in children,and had a higher compliance.It should be widely used in clinics.
出处 《儿科药学杂志》 CAS 2012年第4期19-21,共3页 Journal of Pediatric Pharmacy
关键词 感染 咳嗽 孟鲁司特钠 布地奈德 Infection Cough Montelukast Sodium Budesonide
  • 相关文献

参考文献5

二级参考文献104

共引文献989

同被引文献109

  • 1姚欢银,闫晓勤,楼文勇.白三烯受体拮抗剂孟鲁司特治疗儿童哮喘的临床研究[J].儿科药学杂志,2005,11(5):37-38. 被引量:16
  • 2辛德莉,李贵,李靖,马红秋,陈小庚.北京地区肺炎支原体肺炎的流行状况[J].实用儿科临床杂志,2006,21(16):1054-1055. 被引量:74
  • 3陈灏珠,林果为.实用内科学[M].第13版.北京:人民卫生出版社,2009:2005-2011.
  • 4胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 5胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2012:698-700.
  • 6中华医学会儿科学分会呼吸学组.儿童慢性咳嗽诊断与治疗指南[J].中华儿科杂志,2008,46(2):105-107.
  • 7Sears MK, Radneo F. Safety of budesonide/formoteralmaintenance and relieves therapy in asthma trials [J]. RespirMed, 2009, 103(12): 196.
  • 8Partridge MR, Schuexmann W, Beckman 0,et al. Effecton lungfunction and morning activities of budesorides/formoteral versussalmeteral/fluticasone in patients with COPD [J]. Ther AdvRespir Dis,2009, 3(4) : 1-6.
  • 9Wahn U.What drives the allergic march[J].Allergy,2000,5 (7) :591-599.
  • 10Paleari D, Rossi GA, Nicolini G, et al.Ambroxol : a muhi- faceted molecule with additional therapeutic potentials in respiratory disorders of childhood[J].Expert Opin Drug Dis- coy,2011,6 ( 11 ) : 1203-1214.

引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部